These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8455418)

  • 41. [Portal thrombosis and anticardiolipin antibodies association in an HIV-2 infected patient].
    Bouchard O; Bosseray A; Leclercq P; Micoud M
    Presse Med; 1998 Jun; 27(20):965. PubMed ID: 9767838
    [No Abstract]   [Full Text] [Related]  

  • 42. Protein S and HIV infection. The role of anticardiolipin and anti-protein S antibodies.
    Sorice M; Griggi T; Arcieri P; Circella A; d'Agostino F; Ranieri M; Modrzewska R; Lenti L; Mariani G
    Thromb Res; 1994 Feb; 73(3-4):165-75. PubMed ID: 7910706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. False-positive rapid plasma reagin tests and anti-cardiolipin antibodies.
    MacLean SK; Bordón J
    J Infect Dis; 1995 Sep; 172(3):905-6. PubMed ID: 7658097
    [No Abstract]   [Full Text] [Related]  

  • 44. [Value of anticardiolipin antibody assay in human immunodeficiency virus infection].
    Lafeuillade A; Delbeke E; Chaffanjon P; Aubert L; Dhiver C; Gastaut JA; Quilichini R
    Presse Med; 1990 Jun; 19(26):1225-7. PubMed ID: 2142772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Vitiligo associated with the acquired immunodeficiency syndrome].
    García-Patos Briones V; Rodríguez Cano L; Capdevila Morell JA; Costells Rodellas A
    Med Clin (Barc); 1994 Sep; 103(9):358. PubMed ID: 7967901
    [No Abstract]   [Full Text] [Related]  

  • 46. [A case from practice (330). 1. HIV infection stage CDC A2. 2. Anticardiolipin syndrome].
    Steuerwald M; Gilli L
    Praxis (Bern 1994); 1995 Aug; 84(35):944-6. PubMed ID: 7569530
    [No Abstract]   [Full Text] [Related]  

  • 47. T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
    Winkelstein W
    JAMA; 1992 Nov; 268(18):2515-6; author reply 2517. PubMed ID: 1404815
    [No Abstract]   [Full Text] [Related]  

  • 48. Anticardiolipin antibody and stroke in an HIV-positive patient.
    Thirumalai S; Kirshner HS
    AIDS; 1994 Jul; 8(7):1019-20. PubMed ID: 7946091
    [No Abstract]   [Full Text] [Related]  

  • 49. T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
    Montella F; Di Sora F; Perucci CA; Abeni DD; Recchia O
    JAMA; 1992 Nov; 268(18):2516-7. PubMed ID: 1404816
    [No Abstract]   [Full Text] [Related]  

  • 50. Adult Kawasaki syndrome associated with HIV infection and anticardiolipin antibodies.
    Bayrou O; Phlippoteau C; Artigou C; Haddad T; Leynadier F
    J Am Acad Dermatol; 1993 Oct; 29(4):663-4. PubMed ID: 8408812
    [No Abstract]   [Full Text] [Related]  

  • 51. Antitissue transglutaminase antibodies in HIV infection and effect of highly active antiretroviral therapy.
    Pereda I; Bartolomé-Pacheco MJ; Martín M; López-Escribano H; Echevarría S; López-Hoyos M
    J Acquir Immune Defic Syndr; 2001 Aug; 27(5):507-8. PubMed ID: 11511830
    [No Abstract]   [Full Text] [Related]  

  • 52. The finding of anticardiolipin autoantibodies in patients with pseudoexfoliation syndrome requires further evaluation.
    Philip SS; Khan S
    J Glaucoma; 2012 Mar; 21(3):206; author reply 206-7. PubMed ID: 22366696
    [No Abstract]   [Full Text] [Related]  

  • 53. Reply to bibas et Al.
    Shiels MS; Landgren O; Goedert JJ; Engels EA
    Clin Infect Dis; 2013 May; 56(9):1350. PubMed ID: 23325426
    [No Abstract]   [Full Text] [Related]  

  • 54. [Mortality in people infected by Human Immunodeficiency Virus].
    Berenguer J
    Enferm Infecc Microbiol Clin; 2016 Apr; 34(4):217-8. PubMed ID: 26926261
    [No Abstract]   [Full Text] [Related]  

  • 55. [Anticardiolipin antibodies in patients infected with the human immunodeficiency virus type 1].
    Coll J; Yazbeck H; Gutiérrez J
    Med Clin (Barc); 1993 Mar; 100(9):357-8. PubMed ID: 8455418
    [No Abstract]   [Full Text] [Related]  

  • 56. [Anticardiolipin antibodies in patients infected with the human immunodeficiency virus type 1].
    Selva A; Ordi J; Castro-Salomó A; Pascual M
    Med Clin (Barc); 1993 Mar; 100(9):358. PubMed ID: 8455419
    [No Abstract]   [Full Text] [Related]  

  • 57. Antiphospholipid syndrome in a human immunodeficiency virus 1-infected child.
    Shah I; Chudgar P
    Pediatr Infect Dis J; 2006 Feb; 25(2):185-6. PubMed ID: 16462305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship between plasma microparticles, protein S and anticardiolipin antibodies in patients with human immunodeficiency virus infection.
    Gris JC; Toulon P; Brun S; Maugard C; Sarlat C; Schved JF; Berlan J
    Thromb Haemost; 1996 Jul; 76(1):38-45. PubMed ID: 8819249
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunopathogenesis and immunotherapy in AIDS virus infections.
    Letvin NL; Walker BD
    Nat Med; 2003 Jul; 9(7):861-6. PubMed ID: 12835706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human immunodeficiency virus type 1 infection, mucosal immunity, and pathogenesis and extramural research programs at the National Institutes of Health.
    Kresina TF; Mathieson B
    J Infect Dis; 1999 May; 179 Suppl 3():S392-6. PubMed ID: 10099104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.